The Anthropic IPO · A Catholic investor primer

Anthropic through a Catholic lens

Anthropic, the company behind Claude, is set to list on Nasdaq as ANT. We ran it against the U.S. bishops’ investment guidelines. Here’s what we found.

Keep reading

Unlock our analysis

See how Anthropic measures up against our screens, where we stand on the weapons question, and the six places a faithful shareholder would push the company. Enter your email for instant access.

By submitting this form, you are consenting to receiving communications from Arimathea. You can unsubscribe at any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

$70–78Proposed price range per share (preliminary)

$33.2BRevenue, first nine months of 2026

$1.26BOperating loss, same nine months

61%Of shareholder votes held by the co-founders

Our initial read

Eight of nine zero-tolerance screens clear. The weapons screen is still open in our review.

This is a first look, not a completed review. Clearing a screen is not an endorsement, and we still have concerns, including staff fertility benefits that fund IVF (see What we’re watching).

Life

No abortion, contraception or embryo research.

Dignity

Its usage policy bans sexually explicit content and erotic chat.

Purpose

A public benefit company. An independent trust picks most of its board.

Our IPO approach

We usually stay out of IPOs. New listings often swing hard early on, and waiting lets us see how a company’s policies hold up in public: in its annual reports, proxy statements and shareholder votes.

An initial research read as of November 16, 2026. Not a rating, and not a recommendation to buy or sell any security. Screened against Arimathea’s interpretation of the USCCB Socially Responsible Investment Guidelines (2021). The weapons question remains open in our review. Offering terms are preliminary until pricing, expected November 18, 2026. Disclosure: Arimathea’s research platform uses Anthropic’s AI models. Arimathea is not affiliated with Anthropic. Sources and important disclosures below.

Anthropic wouldn’t let its AI run fully autonomous weapons or mass surveillance. It held that line under pressure from the Pentagon.

“It is not permissible to entrust lethal or otherwise irreversible decisions to artificial systems. No algorithm can make war morally acceptable.”

Pope Leo XIV, Magnifica Humanitas, 198

The refusal

Asked to allow “all lawful purposes,” Anthropic said no. Its filing says the Pentagon floated the Defense Production Act to force its hand.

What happened next

In February 2026, federal agencies were told to stop using its technology. In March, the Pentagon labeled it a supply-chain risk. The courts have split.

U.S. policy

Requires “appropriate levels of human judgment over the use of force,” but still allows autonomous weapons after a senior review.

Still open in our review

Press reports say Claude suggested and ranked targets in the 2026 Iran campaign. Its CEO says the company doesn’t know exactly how its models were used.

Our read: on who decides to use lethal force, Anthropic stands with the encyclical, and goes further than Washington.

The weapons question remains open in our review. Reports on military use rely on anonymous sources and are not confirmed by the Pentagon.

What we’re watching

Six places a faithful shareholder would push Anthropic, and what we’d ask for.

  1. 01War

    Press reports say Claude suggested and ranked targets in the 2026 Iran campaign. Its CEO says the company doesn’t know exactly how its models were used.

    Ask: make military use traceable, as the encyclical requires, and audit whether the autonomous-weapons limit is holding.

  2. 02Work

    Its own CEO has warned AI could wipe out half of entry-level office jobs.

    Ask: show how the Public Benefit Fund will help people who lose their jobs.

  3. 03Creation

    The filing has no numbers on emissions, energy or water.

    Ask: publish the numbers, and set targets.

  4. 04Family

    Employees get 22 weeks of paid parental leave. Their fertility benefit runs through Carrot Fertility, which funds IVF.

  5. 05Values

    Claude’s constitution treats a “true, universal ethics” as an open question, with fallbacks if none exists. The Church holds that reason can discover moral values that apply to everyone (MH 56).

    Ask: say plainly that objective moral truth governs the constitution.

  6. 06Consciousness

    Its CEO says the company doesn’t know if its models are conscious, and it studies “model welfare.” The encyclical says AI doesn’t have experiences or feel joy or pain (MH 99).

    Ask: commit that Claude won’t present itself as conscious, and disclose what that welfare work involves and costs.

The Anthropic IPO

Important disclosures

About this research

This is Arimathea’s initial research read on Anthropic as of November 16, 2026. It is not a rating or a completed Arimathea score card, and it is not a recommendation to buy, sell or hold any security, including Anthropic (ANT). It is for general information only and is not individualized investment, legal or tax advice. Our views may change without notice.

The offering and risk

Offering terms come from Anthropic’s preliminary prospectus (Form S-1/A, filed November 10, 2026) and may change until pricing, expected November 18, 2026. Newly listed shares can be highly volatile. All investing involves risk, including possible loss of principal.

Faith-based screening

Arimathea screens companies using its own interpretation of the USCCB Socially Responsible Investment Guidelines (2021). Values-based screening limits the investment universe, and results may differ from strategies that do not screen. The USCCB and the Holy See have not reviewed or endorsed this material or Arimathea. The weapons question remains open in our review.

Sources

Anthropic’s Form S-1/A, Usage Policy, published constitution, and careers and research pages; Magnifica Humanitas (Vatican English text, May 2026), paragraphs 56, 99 and 198–200; DoD Directive 3000.09; federal court rulings; and reporting by the Washington Post, Bloomberg, Axios and the New York Times. Reports on military use rely on anonymous sources and are not confirmed by the Pentagon. We believe these sources are reliable but do not guarantee their accuracy or completeness.

Conflicts and affiliations

Disclosure: Arimathea’s research platform uses Anthropic’s AI models, and this material was drafted with the help of Claude. Arimathea is not affiliated with, sponsored by or endorsed by Anthropic; Anthropic, Claude and ANT are named for identification only. Arimathea, its personnel and its clients may buy or sell securities discussed here.

About Arimathea

Arimathea, Corp. is an investment adviser registered with the SEC (CRD #330140). Registration does not imply a certain level of skill or training. Our Form ADV Part 2A and Form CRS are available at adviserinfo.sec.gov.